Sun Life's Bright Paper reports explore the latest trends in group benefits. Our research and thoughtful analysis can help you
make the best decisions to support employee health.

New Releases

Long COVID

Reduce long COVID impacts
in your workplace

Mental Health

Employers are taking action right now to address the mental health crisis

Pharmaceutical Benefits

Access to high-cost drugs for
rare diseases

Reduce long COVID impacts in your workplace

Our new Bright Paper report examines what long COVID is, the effects on organizations, and actions you can take to best support your employees struggling with long term symptoms.

Employers are taking action right now to address the mental health crisis

In this Bright Paper report, follow the inspiring, real-life stories of three employers.



From pilot to launch: closing the gaps around access to mental health care

This Bright Paper report explores two innovative solutions to support plan members mental health.

Make the link: healthy lifestyles and mental health

In this Bright Paper report, discover the 5 lifestyle factors that support mental health.
 

Mental health in the workplace: A little training goes a long way

In this Bright Paper report, find out the benefits of mental health training for managers.

Lumino Health Virtual Care, 
powered by Dialogue


Our Bright Paper highlights the ways our new and unique Digital health care partner can support your employees’ health care needs.

Learn more

Virtual care.
Its time has come


This Bright Paper report focuses on the importance of virtual care services to support the physical and mental health of your plan members.

Learn more

Changing times: evolving the approach to disability management

How disability is approached must evolve. There is a clear need for innovation and new options.

Innovations in Absence and Disability Management

This Bright Paper report shows how digital innovations and pharmacogenomics are reducing the effects of disability in the workplace.

Changing the face of cancer

In this Bright Paper report, employers can learn how to make a positive impact in their workplace by creating a cancer action plan to support their employees.
 

Chronic disease in the workplace: Focus on prevention and support

Learn in this Bright Paper report how to address the issue of chronic disease and how to build a healthy future for your employees and your organization.

Access to high-cost drugs for rare diseases

Private health plans currently cover more than 13,000 Canadians with rare diseases. The total spend on rare disease drugs alone by Canadian private plans was approximately $650 million in 2020.1

Our new Bright Paper sets out the issues and highlights the importance of private payer participation in any new strategy.

1Based on data collected from CLHIA member companies. The list of drugs used is based on the Patented Medicine Prices Review Board’s list of rare disease drugs (2018) plus additional drugs that have launched since 2018.